Discure Technologies
Herzliya
About Discure Technologies
Discure Technologies is developing a minimally invasive, implantable bioelectronic device designed to treat and reverse degenerative disc disease (DDD), healing the disc, reducing pain, and restoring function to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: discuremd.com
- Phone: [email protected]
Industries & Categories
Medical Device
Social Profiles
Canonical: https://fsome.com/organization/discure-technologies-30084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.